Sequent Scientific posts Rs 30.53 crore profit for Q2 Ruby Khatun Khatun13 Nov 2017 9:45 AM ISTNew Delhi: Drug firm Sequent Scientific reported a consolidated net profit of Rs 30.53 crore for the quarter ending September 30.The company had...
Drugmaker Hikma cuts generics sales forecast a third time Ruby Khatun Khatun13 Nov 2017 9:30 AM ISTHikma Pharmaceuticals Plc on Thursday lowered 2017 revenue guidance for its generics business for the third time.The Jordan-based firm, which makes...
Hester Biosciences Q2 Net up 48 percent at Rs 8.85 crore Ruby Khatun Khatun13 Nov 2017 9:10 AM ISTNew Delhi: Animal healthcare firm Hester Biosciences reported a 47.99 percent rise in its standalone net profit to Rs 8.85 crore for the September...
Novartis India Q2 net up 18 percent at Rs 26 crore Ruby Khatun Khatun12 Nov 2017 10:30 AM ISTNew Delhi: Drug firm Novartis India reported a 17.60 percent rise in its net profit to Rs 26.12 crore for the quarter ended September 30, 2017.The...
UE LifeSciences in distribution partnership with GE Healthcare Ruby Khatun Khatun12 Nov 2017 10:15 AM ISTBengaluru: UE LifeSciences Inc, a USA-India based med-tech startup, announced a distribution partnership with GE Healthcare to commercialize its...
Dr Lal Path Labs Q2 net profit dips 4 percent at Rs 50.9 crore Ruby Khatun Khatun12 Nov 2017 10:00 AM ISTNew Delhi: Diagnostic chain Dr. Lal Path Labs reported a 3.96 percent dip in its consolidated net profit to Rs 50.9 crore for the September quarter of...
Merck KGaA has contacted prospective buyers of consumer health Ruby Khatun Khatun12 Nov 2017 9:45 AM ISTFRANKFURT: Germany’s Merck KGaA said it has sent information documents on its consumer health business to prospective buyers, kicking off an auction,...
AstraZeneca rides China wave as rival GlaxoSmithKline struggles Ruby Khatun Khatun12 Nov 2017 9:30 AM ISTLONDON: AstraZeneca is enjoying booming drug sales in China, helped by reforms to the country’s regulatory system and an increased sales force, in...
Hikma, Vectura in dispute with FDA over generic Advair Ruby Khatun Khatun12 Nov 2017 9:00 AM ISTLONDON: Hikma and its partner Vectura are in dispute with the Food and Drug Administration over their plans to launch a generic copy of...
Aurobindo Pharma Q2 net up 29 percent at Rs 780.97 crore Ruby Khatun Khatun11 Nov 2017 10:47 AM ISTNew Delhi: Drug firm Aurobindo Pharma reported a 28.96 percent rise in its consolidated net profit to Rs 780.97 crore for the September quarter of the...
Morepen Labs ties up with Vesale Pharma of Belgium Ruby Khatun Khatun11 Nov 2017 10:32 AM ISTNew Delhi: Morepen Laboratories Ltd. entered into a tie-up with Vesale Pharma International of Belgium to strengthen its position in the Rs. 1000...
Alkem Labs Q2 Net up 14 percent at Rs 327.44 crore Ruby Khatun Khatun11 Nov 2017 10:16 AM ISTNew Delhi: Drug firm Alkem Laboratories reported a 13.63 percent rise in consolidated net profit at Rs 327.44 crore for the quarter ended September 30...
